No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Renaissance Technologies Jim Simons	130,200	$1,400,952	-2%	0%
2.	Citadel Investment Group Ken Griffin	38,061	$409,536	+25%	0%
3.	Millennium Management Israel Englander	26,420	$284,279	-6%	0%

Institutional Investors' Holdings

Filing Period: Filing is Ongoing

No.	Name	Shares	Value	% Port
1.	Farther Finance Advisors, Llc	0	$0	0%

News See All

GSK Bets on HUTCHMED to Expand its Multi-Billion-Dollar Oncology Opportunity

On September 3, HUTCHMED (China) Limited (NASDAQ:HCM) announced an exclusive global development and licensing agreement with GSK plc (NYSE:GSK) for HMPL-A830, targeting colorectal, pancreatic, and lung...

Keep Reading →

September 24th, 2026 - Hedge Funds News

HUTCHMED Stock (HCM) Rallies Over 15% on a Major Licensing Deal

HUTCHMED stock soared on Thursday after the company announced a new licensing deal with GlaxoSmithKline.

Keep Reading →

September 3rd, 2026 - TipRanks

Why HUTCHMED (China) Limited (HCM) Is Gaining Attention After China Biotech Re-Rating

We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. HUTCHMED (China) Limited (NASDAQ:HCM) is one of the most undervalued pharma stocks.

Keep Reading →

June 2nd, 2026 - News

11 Most Undervalued Pharma Stocks to Invest In

In this article, we will be taking a look at the 11 Most Undervalued Pharma Stocks to Invest In.

Keep Reading →

May 31st, 2026 - Hedge Funds News

Paycom Software, Inc. (PAYC): A Bull Case Theory

We came across a bullish thesis on Paycom Software, Inc. on The Wealth Dynasty Report’s Substack. In this article, we will summarize the bulls’ thesis on PAYC.

Keep Reading →

February 2nd, 2026 - News Stock Analysis

10 Cheap Pharmaceutical Stocks to Buy According to Short Sellers

In this piece, we will take a look at the 10 cheap pharmaceutical stocks to buy according to short sellers. The pharmaceutical industry is one of the most interesting sectors to invest in.

Keep Reading →

August 27th, 2024 - News Quantitative Investing